Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice

Lili A. Barouch, Thomas P. Cappola, Robert W. Harrison, Julie K. Crone, E. Rene Rodriguez, Arthur L. Burnett, Joshua Hare

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Deficiency of either neuronal nitric oxide synthase (NOS1) or endothelial nitric oxide synthase (NOS3) leads to cardiac hypertrophy in mice. Loss of both produces concentric left ventricular (LV) remodeling, in which increased wall thickness is accompanied by reduced cavity size. In humans, this phenotype develops in elderly hypertensive patients and independently predicts mortality. Accordingly, we tested the hypothesis that NOS1/3-/- mice have reduced longevity compared to either NOS1-/- or NOS3-/-. Survival data on colonies of NOS1-/- (n = 295), NOS3-/- (n = 525), and NOS1/3-/- (n = 331) mice were collected for 2 years. NOS1-/- mice had increased mortality compared to NOS3-/- (relative risk, RR 2.5, P < 0.001), whereas NOS1/3-/- fared significantly worse (RR 7.3, P < 0.001 vs. NOS3-/-). Importantly, gender did not affect survival in NOS1-/- or NOS3-/-, but male NOS1/3-/- mice had 2-fold increased mortality compared to females. NOS1/3-/- mice developed progressive myocyte hypertrophy and interstitial fibrosis with age. NOS1/3-/- mice underwent in vivo hemodynamic analysis with a combined pressure-volume catheter to assess age-related cardiovascular changes. Compared with control, NOS1/3-/- demonstrated hypertension and hypercontractility at all ages, and developed passive diastolic dysfunction with increasing age. Thus, combined deficiency of NOS1 and NOS3 causes increased mortality, myocyte hypertrophy, and an age-associated increase in ventricular stiffness. These findings suggest that cardiac NO signals may play an essential role in successful cardiac aging.

Original languageEnglish
Pages (from-to)637-644
Number of pages8
JournalJournal of Molecular and Cellular Cardiology
Volume35
Issue number6
DOIs
StatePublished - Jun 1 2003
Externally publishedYes

Fingerprint

Nitric Oxide Synthase Type I
Premature Mortality
Nitric Oxide Synthase Type III
Mortality
Muscle Cells
Hypertrophy
Ventricular Remodeling
Survival
Cardiomegaly
Fibrosis
Catheters
Hemodynamics
Hypertension
Phenotype
Pressure

Keywords

  • Aging
  • Gender
  • Hemodynamics
  • Hypertrophy
  • Murine
  • Nitric oxide synthase
  • Survival

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice. / Barouch, Lili A.; Cappola, Thomas P.; Harrison, Robert W.; Crone, Julie K.; Rodriguez, E. Rene; Burnett, Arthur L.; Hare, Joshua.

In: Journal of Molecular and Cellular Cardiology, Vol. 35, No. 6, 01.06.2003, p. 637-644.

Research output: Contribution to journalArticle

Barouch, Lili A. ; Cappola, Thomas P. ; Harrison, Robert W. ; Crone, Julie K. ; Rodriguez, E. Rene ; Burnett, Arthur L. ; Hare, Joshua. / Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice. In: Journal of Molecular and Cellular Cardiology. 2003 ; Vol. 35, No. 6. pp. 637-644.
@article{1402246d85d04b508dc525e783b9b33f,
title = "Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice",
abstract = "Deficiency of either neuronal nitric oxide synthase (NOS1) or endothelial nitric oxide synthase (NOS3) leads to cardiac hypertrophy in mice. Loss of both produces concentric left ventricular (LV) remodeling, in which increased wall thickness is accompanied by reduced cavity size. In humans, this phenotype develops in elderly hypertensive patients and independently predicts mortality. Accordingly, we tested the hypothesis that NOS1/3-/- mice have reduced longevity compared to either NOS1-/- or NOS3-/-. Survival data on colonies of NOS1-/- (n = 295), NOS3-/- (n = 525), and NOS1/3-/- (n = 331) mice were collected for 2 years. NOS1-/- mice had increased mortality compared to NOS3-/- (relative risk, RR 2.5, P < 0.001), whereas NOS1/3-/- fared significantly worse (RR 7.3, P < 0.001 vs. NOS3-/-). Importantly, gender did not affect survival in NOS1-/- or NOS3-/-, but male NOS1/3-/- mice had 2-fold increased mortality compared to females. NOS1/3-/- mice developed progressive myocyte hypertrophy and interstitial fibrosis with age. NOS1/3-/- mice underwent in vivo hemodynamic analysis with a combined pressure-volume catheter to assess age-related cardiovascular changes. Compared with control, NOS1/3-/- demonstrated hypertension and hypercontractility at all ages, and developed passive diastolic dysfunction with increasing age. Thus, combined deficiency of NOS1 and NOS3 causes increased mortality, myocyte hypertrophy, and an age-associated increase in ventricular stiffness. These findings suggest that cardiac NO signals may play an essential role in successful cardiac aging.",
keywords = "Aging, Gender, Hemodynamics, Hypertrophy, Murine, Nitric oxide synthase, Survival",
author = "Barouch, {Lili A.} and Cappola, {Thomas P.} and Harrison, {Robert W.} and Crone, {Julie K.} and Rodriguez, {E. Rene} and Burnett, {Arthur L.} and Joshua Hare",
year = "2003",
month = "6",
day = "1",
doi = "10.1016/S0022-2828(03)00079-8",
language = "English",
volume = "35",
pages = "637--644",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice

AU - Barouch, Lili A.

AU - Cappola, Thomas P.

AU - Harrison, Robert W.

AU - Crone, Julie K.

AU - Rodriguez, E. Rene

AU - Burnett, Arthur L.

AU - Hare, Joshua

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Deficiency of either neuronal nitric oxide synthase (NOS1) or endothelial nitric oxide synthase (NOS3) leads to cardiac hypertrophy in mice. Loss of both produces concentric left ventricular (LV) remodeling, in which increased wall thickness is accompanied by reduced cavity size. In humans, this phenotype develops in elderly hypertensive patients and independently predicts mortality. Accordingly, we tested the hypothesis that NOS1/3-/- mice have reduced longevity compared to either NOS1-/- or NOS3-/-. Survival data on colonies of NOS1-/- (n = 295), NOS3-/- (n = 525), and NOS1/3-/- (n = 331) mice were collected for 2 years. NOS1-/- mice had increased mortality compared to NOS3-/- (relative risk, RR 2.5, P < 0.001), whereas NOS1/3-/- fared significantly worse (RR 7.3, P < 0.001 vs. NOS3-/-). Importantly, gender did not affect survival in NOS1-/- or NOS3-/-, but male NOS1/3-/- mice had 2-fold increased mortality compared to females. NOS1/3-/- mice developed progressive myocyte hypertrophy and interstitial fibrosis with age. NOS1/3-/- mice underwent in vivo hemodynamic analysis with a combined pressure-volume catheter to assess age-related cardiovascular changes. Compared with control, NOS1/3-/- demonstrated hypertension and hypercontractility at all ages, and developed passive diastolic dysfunction with increasing age. Thus, combined deficiency of NOS1 and NOS3 causes increased mortality, myocyte hypertrophy, and an age-associated increase in ventricular stiffness. These findings suggest that cardiac NO signals may play an essential role in successful cardiac aging.

AB - Deficiency of either neuronal nitric oxide synthase (NOS1) or endothelial nitric oxide synthase (NOS3) leads to cardiac hypertrophy in mice. Loss of both produces concentric left ventricular (LV) remodeling, in which increased wall thickness is accompanied by reduced cavity size. In humans, this phenotype develops in elderly hypertensive patients and independently predicts mortality. Accordingly, we tested the hypothesis that NOS1/3-/- mice have reduced longevity compared to either NOS1-/- or NOS3-/-. Survival data on colonies of NOS1-/- (n = 295), NOS3-/- (n = 525), and NOS1/3-/- (n = 331) mice were collected for 2 years. NOS1-/- mice had increased mortality compared to NOS3-/- (relative risk, RR 2.5, P < 0.001), whereas NOS1/3-/- fared significantly worse (RR 7.3, P < 0.001 vs. NOS3-/-). Importantly, gender did not affect survival in NOS1-/- or NOS3-/-, but male NOS1/3-/- mice had 2-fold increased mortality compared to females. NOS1/3-/- mice developed progressive myocyte hypertrophy and interstitial fibrosis with age. NOS1/3-/- mice underwent in vivo hemodynamic analysis with a combined pressure-volume catheter to assess age-related cardiovascular changes. Compared with control, NOS1/3-/- demonstrated hypertension and hypercontractility at all ages, and developed passive diastolic dysfunction with increasing age. Thus, combined deficiency of NOS1 and NOS3 causes increased mortality, myocyte hypertrophy, and an age-associated increase in ventricular stiffness. These findings suggest that cardiac NO signals may play an essential role in successful cardiac aging.

KW - Aging

KW - Gender

KW - Hemodynamics

KW - Hypertrophy

KW - Murine

KW - Nitric oxide synthase

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0038798018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038798018&partnerID=8YFLogxK

U2 - 10.1016/S0022-2828(03)00079-8

DO - 10.1016/S0022-2828(03)00079-8

M3 - Article

VL - 35

SP - 637

EP - 644

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 6

ER -